OPG KO has been shown to inhibit the protein expression of Fatty Acid Synthase (FASN), an essential enzyme that is involved in the fatty acid biosynthetic pathway and is vital for breast cancer existence [125]. The gene discussed is TNFRSF11B; the disease is breast carcinoma.